Nothing Found
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
CVVR Clinical Trials Unit
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
A City in Brazil’s Amazon Rain Forest Is a Stark Warning about COVID to the Rest of the World
/in NewsManaus and cities like it will continue to generate dangerous viral variants if vaccination campaigns are not expanded to broadly reach all nations, rich or poor. Read Article
Plan to Ditch the Mask After Vaccination? Not So Fast.
/in NewsIt’s not clear how easily vaccinated people may spread the virus, but the answer to that question is coming soon. Until then, scientists urge caution. Read Article
Merck to help rival Johnson & Johnson make COVID-19 vaccine
/in NewsThe pharmaceutical giant Merck will help manufacture the newly authorized single-shot COVID-19 vaccine of its rival Johnson & Johnson. Read Article
The first Johnson & Johnson vaccines have been shipped. What’s next?
/in NewsIf Pfizer and Moderna threw the first big punches, if all goes well, Johnson & Johnson may be the blow that COVID never saw coming. NBC News Correspondent Ellison Barber, […]
Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease
/in NewsResearchers in gene-based technology produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come. Read Article
Johnson & Johnson Vaccine ‘Particularly Good For Mass Vaccination Campaigns,’ Boston Doctor Says
/in NewsRead Article
FDA issues emergency use authorization for Johnson & Johnson vaccine
/in NewsThis is the third COVID-19 vaccine authorized by the FDA and the first one that requires just one dose. Read Article
What the latest Johnson & Johnson COVID vaccine data really means
/in NewsRead Article
New analysis finds Johnson & Johnson’s coronavirus vaccine works well
/in NewsThere is promising new data today on Johnson & Johnson’s coronavirus vaccine. If approved, it would add a third option to the vaccine rollout in the United States. Read Article […]
Johnson & Johnson Vaccine Inches Closer To Being Authorized For Emergency Use
/in News